Comparison of Pharmacological Properties between the Kappa Opioid Receptor Agonist Nalfurafine and 42B, Its 3-Dehydroxy Analogue: Disconnect between in Vitro Agonist Bias and in Vivo Pharmacological Effects-Reference-Cited by-同舟云学术

Comparison of Pharmacological Properties between the Kappa Opioid Receptor Agonist Nalfurafine and 42B, Its 3-Dehydroxy Analogue: Disconnect between in Vitro Agonist Bias and in Vivo Pharmacological Effects

Published:2020-09-08 Issue:19 Volume:11 Page:3036-3050
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Cao Danni¹²,Huang Peng¹,Chiu Yi-Ting¹,Chen Chongguang¹,Wang Huiqun³,Li Mengchu³,Zheng Yi³,Ehlert Frederick J.⁴,Zhang Yan³^ORCID,Liu-Chen Lee-Yuan¹^ORCID

Affiliation:

1. Center for Substance Abuse Research, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania 19140, United States

2. Beijing Key Laboratory of Neuropsychopharmacology, State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China

3. Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298, United States

4. Department of Pharmaceutical Sciences, Center of Health Sciences, University of California, Irvine, California 92697, United States

Funder

National Institute on Drug Abuse

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.0c00407

Reference81 articles.

1. Analgesic Efficacy of Enadoline Versus Placebo or Morphine in Postsurgical Pain